Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Short term Debt (2017)

Historic Short term Debt for Aclaris Therapeutics (ACRS) over the last 1 years, with Q4 2017 value amounting to $590000.0.

  • Aclaris Therapeutics' Short term Debt changed N/A to $590000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $590000.0, marking a year-over-year change of. This contributed to the annual value of $590000.0 for FY2017, which is N/A changed from last year.
  • Aclaris Therapeutics' Short term Debt amounted to $590000.0 in Q4 2017.
  • In the past 5 years, Aclaris Therapeutics' Short term Debt ranged from a high of $590000.0 in Q4 2017 and a low of $590000.0 during Q4 2017